Integral Derivatives’s Oracle ORCL Stock Holding History

Integral Derivatives’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-56,390	Closed	-$2.8M	–	909
2017 Q4	$2.67M	Buy	56,390 +47,854	+561%	+$2.35M	0.05%	228
2017 Q3	$413K	Buy	+8,536	New	+$425K	0.01%	790
2017 Q1	–	Sell	-5,549	Closed	-$231K	–	1318
2016 Q4	$213K	Sell	5,549 -45,540	-89%	-$1.78M	﹤0.01%	989
2016 Q3	$2.01M	Buy	51,089 +14,999	+42%	+$611K	0.04%	266
2016 Q2	$1.48M	Buy	+36,090	New	+$1.44M	0.04%	302
2015 Q3	–	Sell	-121,564	Closed	-$4.67M	–	1224
2015 Q2	$4.9M	Buy	+121,564	New	+$5.27M	0.13%	133
2015 Q1	–	Sell	-52,482	Closed	-$2.27M	–	1316
2014 Q4	$2.36M	Sell	52,482 -31,609	-38%	-$1.29M	0.04%	383
2014 Q3	$3.22M	Buy	+84,091	New	+$3.4M	0.06%	313

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Integral Derivatives's ORCL Position: Q1 2018 in Review

Integral Derivatives sold out of Oracle (ORCL) in Q1 2018, closing a stake of 56,390 shares — an estimated $2.8M sold.

Integral Derivatives first reported a position in ORCL in Q3 2014 and held it in 8 quarters. The position peaked at $4.9M in Q2 2015. 1,753 funds tracked by Wall St. Rank hold ORCL as of Q1 2018.

Integral Derivatives reported no remaining Oracle position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 56,390 Oracle shares in Q1 2018, an estimated $2.8M.
Integral Derivatives first reported a position in Oracle in Q3 2014 and held it in 8 quarters.
Integral Derivatives's Oracle position peaked at $4.9M in Q2 2015.
1,753 funds tracked by Wall St. Rank held Oracle as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.